Christopher J. Kirk

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Marc Belsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher J. Kirk:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kezar Life Sciences, Inc. CEO, Director Employee Stock Option (right to buy) 120,000 09 Jan 2025 Direct

Insider Reports Filed by Christopher J. Kirk

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KZR Kezar Life Sciences, Inc. 09 Jan 2025 1 $0 4 CEO, Director 13 Jan 2025, 16:15
KZR Kezar Life Sciences, Inc. 08 Nov 2023 1 $0 4 CEO, Director 09 Nov 2023, 16:25
KZR Kezar Life Sciences, Inc. 24 Jul 2023 10 $0 4 Director 26 Jul 2023, 17:05
KZR Kezar Life Sciences, Inc. 20 Jul 2023 2 $44,055 4 Director 24 Jul 2023, 16:20
KZR Kezar Life Sciences, Inc. 08 Jan 2023 1 $0 4 President and CSO, Director 10 Jan 2023, 15:57
KZR Kezar Life Sciences, Inc. 23 Jun 2022 2 $29,754 4 President and CSO, Director 27 Jun 2022, 18:30
KZR Kezar Life Sciences, Inc. 05 Jan 2022 1 $0 4 President and CSO, Director 07 Jan 2022, 16:30